Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.11.23 | Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Positive Data from Prurigo Nodularis Phase 1b Study Demonstrating Meaningful Reduction in Itch and Skin Clearing with Single Dose 3.0 mg/kg Barzolvolimab | 207 | GlobeNewswire (Europe) | - Response observed as early as week 1 and durable for up to 16 weeks -- Data support important role for mast cells in the pathogenesis of PN and potentially other chronic itch indications -- Phase... ► Artikel lesen | |
05.11.23 | Tenaris SA: Tenaris to Commence a USD 300 million First Tranche of its USD 1.2 Billion Share Buyback Program | 615 | GlobeNewswire (Europe) | LUXEMBOURG, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) ("Tenaris") announced today that pursuant to its Share Buyback Program (the "Program") announced on... ► Artikel lesen | |
05.11.23 | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis | 612 | GlobeNewswire (Europe) | MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First placebo-controlled randomized trial in active psoriatic arthritis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 446 |
EVOTEC | 414 |
TUI | 315 |
NVIDIA | 254 |
BAYER | 234 |
DEUTSCHE BANK | 228 |
NEL | 213 |
PLUG POWER | 210 |
RHEINMETALL | 190 |
SIEMENS ENERGY | 176 |
COMMERZBANK | 165 |
BARRICK GOLD | 147 |
TESLA | 146 |
BASF | 141 |
VOLKSWAGEN | 138 |
BYD | 137 |
RWE | 136 |
DEUTSCHE LUFTHANSA | 133 |
DEUTSCHE TELEKOM | 125 |
ALLIANZ | 122 |
MERCEDES-BENZ | 117 |
RENK GROUP | 115 |
ALIBABA | 107 |
REDCARE PHARMACY | 107 |
E.ON | 106 |